The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
No demonstrable association between the Leningrad-Zagreb mumps vaccine strain and aseptic meningitis in a large clinical trial in Egypt
Open accessAbstract
To address the claim that the Leningrad-Zagreb (L-Z) mumps vaccine strain is causally associated with aseptic meningitis, a prospective, post-marketing safety study was conducted with a measles-mumps-rubella vaccine (MMR) (TRESIVAC(R); Serum Institute of India Ltd., Pune, India), which uses the L-Z strain as its mumps component in Egypt. In all, 453 119 children (65 423 children aged 16-24 months and 329 211 children aged 5-7 years) received MMR. The control groups which, as a result of local health regulations, were slightly younger than vaccinees, comprised 12 253 and 46 232 children, respectively. Using questionnaires, the parents recorded solicited local, systemic and neurological adverse events for up to 42 days post-vaccination. All data were analysed externally on an intention-to-treat basis by individuals not participating in the study. Local and/or systemic reactions were reported in a small percentage of participants, with pain, fever and parotitis being the most common signs among vaccinees in both age groups. No case of aseptic meningitis, encephalitis, anaphylaxis or convulsions was observed in any participant. Thus, in this series of more than 450 000 Egyptian children, the L-Z mumps vaccine strain in this vaccine did not cause aseptic meningitis. The vaccine is considerably cheaper than Western competitors and a valid alternative to other MMR vaccines.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the Sharma 2010 cohort, among older children, fever was reported with slightly higher frequency among unvaccinated children than among MMR-immunised children.
“This trend appeared to be different when the older population was considered; fever had been reported with slightly higher frequency among unvaccinated children.”
From Vaccines for measles, mumps and rubella in children (2012) · cites this paper as Sharma 2010
In the Sharma 2010 cohort, among younger children aged 16 to 24 months, fever during the 42 days postvaccination was reported more frequently among individuals immunised with MMR than among unvaccinated individuals.
“Considering the cohort of Sharma 2010 only within the subgroup of younger children (16 to 24 months of age), fever during the 42 days postvaccination had been reported more frequently among individuals immunised with MMR than among unvaccinated individuals.”
From Vaccines for measles, mumps and rubella in children (2012) · cites this paper as Sharma 2010
Citations
Cites
Pagano, M., Gauvreau, K., & Mattie, H. (2022) · Chapman & Hall/CRC eBooks · doi:10.1201/9780429340512 · Cited by 928
FREQUENCY OF TRUE ADVERSE REACTIONS TO MEASLES-MUMPS-RUBELLA VACCINE
Peltola, H., & Heinonen, O. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91044-5 · Cited by 212
Mumps Outbreaks in Canada and the United States: Time for New Thinking on Mumps Vaccines
Peltola, H., Kulkarni, P. S., Kapre, S. V., Paunio, M., Jadhav, S. S., & Dhere, R. M. (2007) · Clinical Infectious Diseases · doi:10.1086/520028 · Cited by 143
Self-citationDay-to-Day Reactogenicity and the Healthy Vaccinee Effect of Measles-Mumps-Rubella Vaccination
Virtanen, M., Peltola, H., Paunio, M., & Heinonen, O. P. (2000) · PEDIATRICS · doi:10.1542/peds.106.5.e62 · Cited by 105
Aseptic meningitis after vaccination against measles and mumps.
Čižman, M., Mozetic, M., Rakar, R., Pleterski-Rigler, D., & Susec-Michieli, M. (1989) · PubMed · Cited by 74
da Cunha, S. S., Rodrigues, L. C., Barreto, M. L., & Dourado, I. C. (2002) · Vaccine · doi:10.1016/s0264-410x(01)00438-8 · Cited by 67
A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine
Fujinaga, T., Motegi, Y., Tamura, H., & Kuroume, T. (1991) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199103000-00007 · Cited by 64
BROWN, E., Furesz, J., Dimock, K., et al. (1991) · Vaccine · doi:10.1016/0264-410x(91)90223-s · Cited by 63
da Silveira, C. M., Kmetzsch, C. I., Mohrdieck, R., Sperb, A. F., & Prevots, D. R. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.5.978 · Cited by 60
Schwarzer, S., Reibel, S., Lang, A. B., et al. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00174-6 · Cited by 56
Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population
Ong, G., Goh, K. T., Ma, S., & Chew, S. K. (2005) · Journal of Infection · doi:10.1016/j.jinf.2004.10.001 · Cited by 50
CHANGES IN BRAIN WATER IN SYSTEMIC LUPUS ERYTHEMATOSUS
Houssiau, F., Devogelaer, J., & Mathurin, P. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92036-2 · Cited by 45
Vaccine safety versus vaccine efficacy in mass immunisation programmes
Nokes, D. J., & Anderson, R. M. (1991) · The Lancet · doi:10.1016/0140-6736(91)92601-w · Cited by 42
Thrombocytopenia in Childhood: An Evaluation of 433 Patients
Cohn, J. (1976) · Scandinavian Journal of Haematology · doi:10.1111/j.1600-0609.1976.tb01142.x · Cited by 39
Vaccine-related mumps meningitis--Canada.
Furesz, J., & Contreras, G. (1990) · PubMed · Cited by 34
Arruda, W. O., & Kondageski, C. (2001) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652001000500012 · Cited by 28
MUMPS VACCINE COMPLICATIONS: WHICH STRAIN?
Nalin, D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92004-7 · Cited by 27
Popow‐Kraupp, T., Kundi, M., Ambrosch, F., et al. (1986) · Journal of Medical Virology · doi:10.1002/jmv.1890180109 · Cited by 25
Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil
Oliveira, M. I., Curti, S. P., Figueiredo, C. A., et al. (2002) · Revista de Saúde Pública · doi:10.1590/s0034-89102002000200006 · Cited by 19
Jonville‐Béra, A. ‐., AUTRET, E., Galy-Eyraud, C., & Hessel, L. (1996) · Pharmacoepidemiology and Drug Safety · doi:10.1002/(sici)1099-1557(199601)5:1 · Cited by 19
Aseptic meningitis after vaccination with L-Zagreb mumps strain—Virologically confirmed cases
Tešović, G., & Lesnikar, V. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.025 · Cited by 19
Kulkarni, P. S., Phadke, M., Jadhav, S. S., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.05.029 · Cited by 15
Self-citationTrošelj-Vukić, B., Pavić, I., Milotić, I., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.096 · Cited by 14
Adverse events temporally associated with immunizing agents--1989 report.
DUCLOS, P. J., Koch, J., Hardy, M., et al. (1991) · PubMed · Cited by 12
Adverse events temporally associated with immunizing agents--1987 report.
Koch, J., Leet, C. H., McCarthy, R. A., et al. (1989) · PubMed · Cited by 12
Pharmacovigilance on MMR vaccine containing L-Zagreb mumps strain
Phadke, M., Patki, P. S., Kulkarni, P. S., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.04.002 · Cited by 11
Bock, L. L. (1969) · PEDIATRICS · doi:10.1542/peds.43.5.907 · Cited by 5
Flagged first, then by citations
Research works printed but not linked: 3
- Pan American Health Organization (PAHO), 1999, Special program for vaccines and immunization. Evaluation of the Bahamas’ MMR campaign, EPI Newsl, 21, 4
- MMWR, 1989, Mumps prevention, Morb Mortal Wkly Rep, 38, 388
- CDC Update, 2006, Multistate outbreak of mumps – United States, January 1 – May 2, 2006, Morb Mortal Wkly Rep, 55, 559
Cited by
Sorted by citations
Vaccines for measles, mumps and rubella in children
Demicheli, V., Rivetti, A., Debalini, M. G., & Di Pietrantonj, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004407.pub3 · Cited by 372
Metadata
- Authors
- Sharma, H. J., Aly Oun, S., Abou Bakr, S. S., Kapre, S. V., Jadhav, S. S., Dhere, R. M., & Bhardwaj, S.
- Affiliations
- Serum Institute of India (India) (IN)
- Corresponding author
- Sharma, H.J.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 16
- Issue
- 4
- Pages
- 347-352
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W1565014722
- Cited by
- 13
- References
- 27
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 1 · 2021: 1 · 2020: 2 · 2018: 1 · 2017: 1 · 2015: 1 · 2013: 2 · 2012: 2
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Clinical Microbiology and Infection (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- aseptic meningitis, MMR vaccine, vaccine safety, post-marketing surveillance, adverse events, parotitis, Egyptian children
- MeSH terms
- Child, Child, Preschool, Egypt, Encephalitis, Female, Humans, Infant, Male, Meningitis, Aseptic, Product Surveillance, Postmarketing, Surveys and Questionnaires, Measles-Mumps-Rubella Vaccine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review